KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to -$512.0 million.

  • Boston Scientific's Cash from Investing Activities rose 8617.71% to -$512.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.6 billion, marking a year-over-year increase of 5357.83%. This contributed to the annual value of -$2.6 billion for FY2025, which is 5357.83% up from last year.
  • Latest data reveals that Boston Scientific reported Cash from Investing Activities of -$512.0 million as of Q4 2025, which was up 8617.71% from -$502.0 million recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Cash from Investing Activities ranged from a high of $71.0 million in Q1 2021 and a low of -$3.7 billion during Q4 2024
  • In the last 5 years, Boston Scientific's Cash from Investing Activities had a median value of -$500.0 million in 2025 and averaged -$763.6 million.
  • In the last 5 years, Boston Scientific's Cash from Investing Activities soared by 19342.11% in 2021 and then crashed by 279655.17% in 2023.
  • Over the past 5 years, Boston Scientific's Cash from Investing Activities (Quarter) stood at -$461.0 million in 2021, then surged by 60.3% to -$183.0 million in 2022, then plummeted by 475.41% to -$1.1 billion in 2023, then plummeted by 251.76% to -$3.7 billion in 2024, then surged by 86.18% to -$512.0 million in 2025.
  • Its last three reported values are -$512.0 million in Q4 2025, -$502.0 million for Q3 2025, and -$1.1 billion during Q2 2025.